Researchers studied the literature and western states’ experiences to assess the costs and benefits of telestroke in 90-day and lifetime horizons. They found that compared to usual care, telestroke produced an incremental cost-effectiveness ratio of $108,363 per quality-adjusted life-year in the 90-day horizon and $2,449 per QALY in the lifetime horizon.
The authors suggested telestroke is cost-effective compared to usual care because telestroke requires costs upfront but yields lifelong benefits.
Related Articles on Telestroke:
IU Health Partners With Rural Health Network for Stroke Telemedicine Service
Vanderbilt, Memorial University Medical Centers Create Telemedicine Programs for Stroke Patients
Cleveland Clinic Partners With Pennsylvania Hospital for Stroke Care
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.